IL6 and metabolic dysfunction-associated steatotic liver disease: ,33 Hepatic inflammation in MASLD is known to trigger the release of pro-inflammatory cytokines, such as interleukin-6 and tumor necrosis factor alpha, as well as procoagulant factors, such as plasminogen activator inhibitor-1 and fibrinogen.6